Effects of Anxiolytic Drugs in Animal Models of Multiple Sclerosis

QR Code

Effects of Anxiolytic Drugs in Animal Models of Multiple Sclerosis

None

Saved in:

Bibliographic Details
Main Authors:	Novío, Silvia, Freire-Garabal, Manuel, Núñez-Iglesias, María Jesús
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27662
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mulungu – Rainforest Anxiolytic
by: Jiri, Patocka
Published: (2011)

New Anxiolytic Phytopharmaceutical Elaborated with the Standardized Extract of Galphimia glauca
by: Tortoriello, Jaime, et al.
Published: (2011)

Neuroimaging in Multiple Sclerosis
by: Andreadou, Elisabeth
Published: (2012)

Multiple Sclerosis and Celiac Disease
by: Hernández-Lahoz, Carlos, et al.
Published: (2012)

ANXIOLYTIC EFFECT OF HERBAL REMEDY «NOOPHYT»
by: Ya. G. Razuvaeva, et al.
Published: (2012-07-01)

Bowel Dysfunction in Persons with Multiple Sclerosis
by: Gulick, Elsie E., et al.
Published: (2012)

Animal Models of Drug Addiction
by: Belin-Rauscent, Aude, et al.
Published: (2012)

Mechanisms and Patterns of Axonal Loss in Multiple Sclerosis
by: Harris, Zachary M., et al.
Published: (2012)

Cellular Based Therapies for the Treatment of Multiple Sclerosis
by: Crooks, James, et al.
Published: (2011)

Anxiolytic effect of the extract from Rhaponticum uniflorum roots
by: N. K. Tatarinova, et al.
Published: (2015-04-01)

The features of reproductive health in women with multiple sclerosis
by: O. A. Tikhonovskaya, et al.
Published: (2017-09-01)

Preclinical study the pharmacokinetics new anxiolytic drug of dipeptide structure GB-115
by: V. P. Zherdev, et al.
Published: (2014-04-01)

Impact of Gray Matter Pathology on Cognitive Function in Multiple Sclerosis
by: Andrea, Mike, et al.
Published: (2012)

Time trends incidence of celiac disease in a Spanish population.
by: Julia María Cabo Del Riego, et al.
Published: (2025-01-01)

Pharmacokinetics of dipeptide anxiolytic GB-115 after oral administration in different animals species and humans
by: S. Yu. Raskin, et al.
Published: (2017-07-01)

Use of Animal Models for Anti-HIV Drug Development
by: Ambrose, Zandrea
Published: (2012)

E-Health 2.0 Developments in Treatment and Research in Multiple Sclerosis
by: Jongen, Peter Joseph
Published: (2012)

Antibody-Proteases in the Pathogenesis of Autoimmune Demyelination and Monitoring Patients with Multiple Sclerosis
by: Kostyushev, Dmitry, et al.
Published: (2011)

Perturbation response scanning of drug-target networks: Drug repurposing for multiple sclerosis
by: Yitan Lu, et al.
Published: (2025-06-01)

Immunomodulation of Potent Antioxidant Agents: Preclinical Study to Clinical Application in Multiple Sclerosis
by: Fan, Shyi-Jou Chen Hueng-Chuen, et al.
Published: (2012)

Study of chronic toxicity of potential anxiolytic Homeovox
by: I. A. Miroshkina, et al.
Published: (2020-07-01)

Paramyxoviruses and Multiple Sclerosis
by: Baghdad Science Journal
Published: (2012-09-01)

Ageing and multiple sclerosis
by: Julija Isačenko, et al.
Published: (2024-12-01)

Biomarker Identification in Patients with Multiple Sclerosis Treated with Autologous Hematopoietic Stem Cell Transplantation
by: Moisés Manuel Gallardo-Pérez, et al.
Published: (2025-03-01)

EVALUATION OF ANALGESIC AND ANXIOLYTIC EFFECTS OF PEROVSKIA ABROTANOIDES IN SWISS ALBINO MICE
by: Marvi, et al.
Published: (2025-07-01)

EVALUATION OF ANALGESIC AND ANXIOLYTIC EFFECTS OF PEROVSKIA ABROTANOIDES IN SWISS ALBINO MICE
by: Marvi, et al.
Published: (2025-07-01)

The anxiolytic effect of midazolam in third molar extraction: a systematic review.
by: Qi Chen, et al.
Published: (2015-01-01)

Study of acute toxicity of potential anxiolytic GML-1
by: I. A. Miroshkina, et al.
Published: (2019-01-01)

Multiple sclerosis and pregnancy. Impact of multiple sclerosis disease-modifying therapy on the health of newborns
by: T. I. Yakushina
Published: (2021-02-01)

MR Spectroscopy in Multiple Sclerosis - A New Piece of the Puzzle or Just a New Puzzle
by: Aboul-Enein, Fahmy
Published: (2012)

EVALUATION OF IMMUNOTOXICITY OF THE THERAPEUTIC DRUG PROLONGED ACTION FOR MULTIPLE SCLEROSIS ON RHESUS MONKEYS
by: A. B. Dzheliya, et al.
Published: (2015-10-01)

Pathogenetic therapy of multiple sclerosis
by: N. V. Komissarova, et al.
Published: (2023-09-01)

ERECTILE DYSFUNCTION IN MULTIPLE SCLEROSIS
by: Константин Александрович Бурдин, et al.
Published: (2017-09-01)

Multiple sclerosis: 2024 update
by: Luisa Klotz, et al.
Published: (2025-07-01)

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2010-08-01)

The basis of membrane stabilized effect of kopaxon in multiple sclerosis
by: L. I. Reikhert, et al.
Published: (2009-02-01)

Impact of surgery in patients with multiple sclerosis: a nationwide cohort study
by: Emma Larsson, et al.
Published: (2025-06-01)

Assessment of the life quality of patients with multiple sclerosis using the SF-36 scale
by: N. V. Sturov, et al.
Published: (2024-08-01)

THE EFFICACY OF ANTIHYPERTENSIVE TREATMENT COMBINATION WITH ANXIOLYTICS IN HYPERTENSIVES WITH ANXIETY DISORDER
by: D. V. Kovalev, et al.
Published: (2017-05-01)

The effect of peptide anxiolytic selank on cognitive impairment induced by acute alcohol in adolescent rats
by: Anna Nadorova, et al.
Published: (2019-09-01)